Pharmaceutical preparations for targeting and destroying bacteria; pharmaceutical preparations for the treatment of antibiotic-resistant bacterial infections and microbiome-related disorders; pharmaceutical preparations for use in the field of engineered bacteriophage; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases namely, transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases

'antibiot':15 'antibiotic-resist':14 'autoimmun':52 'bacteri':17 'bacteria':7 'bacteriophag':33 'cancer':51 'cardiovascular':67 'degen':81 'delay':60 'delayed-typ':59 'deliv':37 'dermatolog':77 'design':35 'destroy':6 'diseas':49,55,64,66,70,74,78,80,82,85 'disord':23 'engin':32 'field':30 'gastrointestin':65 'genitourinari':79 'high':38 'hypersensit':62 'infect':18,72 'inflammatori':54 'metabol':69 'microbiom':21 'microbiome-rel':20 'modul':41 'musculoskelet':73 'name':50,56 'ophthalmolog':75 'orphan':84 'pathogen':71 'patient':43 'pharmaceut':1,8,24,34 'prepar':2,9,25 'relat':22 'resist':16 'respiratori':63 'suffer':44 'target':4,39 'therapeut':40 'transplant':57 'treatment':12 'type':61 'use':27 'varieti':47

CRPHAGE

Owners

Goods & Services